Ontology highlight
ABSTRACT:
SUBMITTER: Haas KM
PROVIDER: S-EPMC10533562 | biostudies-literature | 2023 Sep
REPOSITORIES: biostudies-literature
Haas Kelsey M KM McGregor Michael J MJ Bouhaddou Mehdi M Polacco Benjamin J BJ Kim Eun-Young EY Nguyen Thong T TT Newton Billy W BW Urbanowski Matthew M Kim Heejin H Williams Michael A P MAP Rezelj Veronica V VV Hardy Alexandra A Fossati Andrea A Stevenson Erica J EJ Sukerman Ellie E Kim Tiffany T Penugonda Sudhir S Moreno Elena E Braberg Hannes H Zhou Yuan Y Metreveli Giorgi G Harjai Bhavya B Tummino Tia A TA Melnyk James E JE Soucheray Margaret M Batra Jyoti J Pache Lars L Martin-Sancho Laura L Carlson-Stevermer Jared J Jureka Alexander S AS Basler Christopher F CF Shokat Kevan M KM Shoichet Brian K BK Shriver Leah P LP Johnson Jeffrey R JR Shaw Megan L ML Chanda Sumit K SK Roden Dan M DM Carter Tonia C TC Kottyan Leah C LC Chisholm Rex L RL Pacheco Jennifer A JA Smith Maureen E ME Schrodi Steven J SJ Albrecht Randy A RA Vignuzzi Marco M Zuliani-Alvarez Lorena L Swaney Danielle L DL Eckhardt Manon M Wolinsky Steven M SM White Kris M KM Hultquist Judd F JF Kaake Robyn M RM García-Sastre Adolfo A Krogan Nevan J NJ
Nature communications 20230927 1
Influenza A Virus (IAV) is a recurring respiratory virus with limited availability of antiviral therapies. Understanding host proteins essential for IAV infection can identify targets for alternative host-directed therapies (HDTs). Using affinity purification-mass spectrometry and global phosphoproteomic and protein abundance analyses using three IAV strains (pH1N1, H3N2, H5N1) in three human cell types (A549, NHBE, THP-1), we map 332 IAV-human protein-protein interactions and identify 13 IAV-mo ...[more]